What does NeuroLaunch do?

NeuroLaunch is an independent organization dedicated to neuroscience education and neurodiversity assessment tools. Founded in 2020 and based in Amsterdam, the company operates without external investors, relying solely on foundational grants. Its primary offering, the NeuroPassport platform, provides accessible, evidence-based screening for neurodevelopmental conditions such as autism, ADHD, and anxiety. NeuroPassport features a range of online educational tools, including screening questionnaires tailored for different age groups, immediate educational reports, and strategy libraries with resources for families, schools, and healthcare professionals. The assessments are HIPAA-compliant and reviewed by clinical experts, ensuring a secure and reliable experience. With pricing plans starting at $49 per assessment, NeuroLaunch aims to facilitate quick insights for families and professionals, supporting informed conversations about neurodevelopmental health.